Frazier reloads with $1.4B to bet on 'growth buyout' plays — nearly double the last fund
The private equity arm of Frazier Healthcare Partners has collected $1.4 billion for its latest haul, muscling up a growth buyout fund to search for “middle market” companies to take over.
While the growth buyout team has always played a different ball game than its life science venture investment counterpart, the new raise still marks a big jump from the $780 million raised for Frazier Healthcare Growth Buyout Fund IX — reflecting the ambition of both the managers and backers.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.